Cited 61 time in
- Title
- Chitosan-based intelligent theragnosis nanocomposites enable pH-sensitive drug release with MR-guided imaging for cancer therapy
- Author(s)
- Eun Kyung Lim; W Sajomsang; Y Choi; E Jang; H Lee; B Kang; E Kim; S Haam; J S Suh; Sang Jeon Chung; Y M Huh
- Bibliographic Citation
- Nanoscale Research Letters, vol. 8, pp. 467-467
- Publication Year
- 2013
- Abstract
- Smart drug delivery systems that are triggered by environmental conditions have been developed to enhance cancer therapeutic efficacy while limiting unwanted effects. Because cancer exhibits abnormally high local acidities compared to normal tissues (pH 7.4) due to Warburg effects, pH-sensitive systems have been researched for effective cancer therapy. Chitosan-based intelligent theragnosis nanocomposites, N-naphthyl-O-dimethymaleoyl chitosan-based drug-loaded magnetic nanoparticles (NChitosan-DMNPs), were developed in this study. NChitosan-DMNPs are capable of pH-sensitive drug release with MR-guided images because doxorubicin (DOX) and magnetic nanocrystals (MNCs) are encapsulated into the designed N-naphthyl-O-dimethymaleoyl chitosan (N-nap-O-MalCS). This system exhibits rapid DOX release as acidity increases, high stability under high pH conditions, and sufficient capacity for diagnosing and monitoring therapeutic responses. These results demonstrate that NChitosan-DMNPs have potential as theragnosis nanocomposites for effective cancer therapy.
- Keyword
- Cancer therapyDrug deliveryMagnetic resonance imagingNanocompositespH-sensitiveTheragnosis
- ISSN
- 1931-7573
- Publisher
- Springer
- DOI
- http://dx.doi.org/10.1186/1556-276X-8-467
- Type
- Article
- Appears in Collections:
- Division of Research on National Challenges > Bionanotechnology Research Center > 1. Journal Articles
- Files in This Item:
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.